文献
J-GLOBAL ID:202202246738480358
整理番号:22A0737262
2型糖尿病のCOVID-19患者における臨床的悪化および超炎症性症候群のDPP4i減少奇数の使用: 香港における地域全体コホートの傾向スコア分析【JST・京大機械翻訳】
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong
著者 (15件):
Wong Carlos K.H.
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Wong Carlos K.H.
(Department of Family Medicine and Primary Care, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Wong Carlos K.H.
(Laboratory of Data Discovery for Health Limited, Hong Kong Science Park, New Territories, Hong Kong SAR, China)
,
Lui David T.W.
(Division of Endocrinology and Metabolism, Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Lui Angel Y.C.
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Kwok Ashley C.Y.
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Low Marshall C.H.
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Lau Kristy T.K.
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Au Ivan C.H.
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Xiong Xi
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Chung Matthew S.H.
(Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Lau Eric H.Y.
(Laboratory of Data Discovery for Health Limited, Hong Kong Science Park, New Territories, Hong Kong SAR, China)
,
Lau Eric H.Y.
(WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
,
Cowling Benjamin J.
(Laboratory of Data Discovery for Health Limited, Hong Kong Science Park, New Territories, Hong Kong SAR, China)
,
Cowling Benjamin J.
(WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China)
資料名:
Diabetes & Metabolism
(Diabetes & Metabolism)
巻:
48
号:
1
ページ:
Null
発行年:
2022年
JST資料番号:
A1165A
ISSN:
1262-3636
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)